Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,135,936
+$1,858,378 QoQ
Shares Held
236,324
+25.1% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $237,388,644 across 14 Biotechnology names. EXEL ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
100,669 | $77,780,896 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
622,304 | $60,519,064 | |
| 3 | INCY |
Incyte Corp
|
493,713 | $46,468,267 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,160 | $13,949,479 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
236,324 | $10,135,936 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
202,420 | $5,607,034 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
214,587 | $4,669,413 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
23,677 | $4,476,136 |
All Filings in EXEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,135,936 | 236,324 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,277,558 | 188,856 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,806,122 | 116,371 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,779,110 | 85,733 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $272,986 | 7,394 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $247,252 | 7,425 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||